NKG2A blockade potentiates CD8 T-cell immunity induced by cancer vaccines

Tumor-infiltrating CD8 T cells were found to frequently express the inhibitory receptor NKG2A, particularly in immune-reactive environments and after therapeutic cancer vaccination. High dimensional cluster analysis demonstrated that NKG2A marks a unique immune effector subset preferentially co-expr...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cell
Egile Nagusiak: van Montfoort, Nadine, Borst, Linda, Korrer, Michael J., Sluijter, Marjolein, Marijt, Koen A., Santegoets, Saskia J., van Ham, Vanessa J., Ehsan, Ilina, Charoentong, Pornpimol, André, Pascale, Wagtmann, Nicolai, Welters, Marij J.P., Kim, Young J., Piersma, Sytse J., van der Burg, Sjoerd H., van Hall, Thorbald
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2018
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6354585/
https://ncbi.nlm.nih.gov/pubmed/30503208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cell.2018.10.028
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak